Cargando…
Impact of Early Treatment With High-Dose Intravenous Immunoglobulin on Incidence of Kawasaki Disease Complications in Iranian Children
Objective: Kawasaki disease (KD) occurs in five-year-old or younger children. This study aimed to evaluate the impact of high-dose intravenous immunoglobulin plus acetylsalicylic acid therapy on the prevention and treatment of coronary artery lesions and to evaluate the impact of high-dose acetylsal...
Autores principales: | Karimi Yazdi, Alireza, Akbariasbagh, Parvin, Aghighi, Yahya, Raeeskarami, Seyyed Reza, Toomaj, Khadije, Heidari, Sahar, Alamdari, Shahnaz, Sahebi, Leyla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897822/ https://www.ncbi.nlm.nih.gov/pubmed/35340797 http://dx.doi.org/10.18502/jfrh.v15i4.7890 |
Ejemplares similares
-
Intravenous Methylprednisolone Pulse Therapy Versus Intravenous Immunoglobulin in the Prevention of Coronary Artery Disease in Children with Kawasaki Disease: A Randomized Controlled Trial
por: Aslani, Nahid, et al.
Publicado: (2022) -
Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023) -
Evaluation of 10-Year Experience of Wegener's Granulomatosis in Iranian Children
por: Tahghighi, Fatemeh, et al.
Publicado: (2013) -
PReS-FINAL-2083: The rate of malignancy in iranian children with joint manifestations
por: Shafaie, N, et al.
Publicado: (2013) -
Determination of the Relationship Between Kobayashi, Sano, and Egami Criteria and Prevalence of Intravenous Immunoglobulin Resistance and Coronary Artery Aneurysm in Iranian Children with Kawasaki Disease
por: Shashaani, Niloufar, et al.
Publicado: (2020)